- Report
- February 2024
- 204 Pages
Global
From €6963EUR$7,950USD£6,043GBP
- Report
- February 2024
- 360 Pages
Global
From €6963EUR$7,950USD£6,043GBP
- Report
- March 2021
- 149 Pages
Global
From €6087EUR$6,950USD£5,283GBP
- Report
- May 2024
- 140 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- May 2024
- 124 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- March 2024
- 136 Pages
Global
From €3722EUR$4,250USD£3,231GBP
- Report
- January 2022
- 132 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- October 2024
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- February 2024
- 120 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- July 2023
- 110 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- December 2022
- 119 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- August 2022
- 120 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- October 2024
- 250 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- April 2024
- 140 Pages
Global
From €4352EUR$4,969USD£3,777GBP
- Report
- May 2023
- 147 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- May 2023
- 140 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- December 2023
- 140 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- January 2025
- 97 Pages
Middle East, Africa
From €3022EUR$3,450USD£2,623GBP
- Report
- January 2025
- 104 Pages
North America
From €3022EUR$3,450USD£2,623GBP
- Report
- January 2025
- 110 Pages
Europe
From €3022EUR$3,450USD£2,623GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more